A perspective on nanomedicine: focus on cardiovascular medicine
Background: Nanomedicine refers to the application of nanotechnology to improve the diagnosis, monitoring and treatment of diseases. Although the primary application was originally in oncology, nanomedicine has witnessed substantial scientific interest and growth beyond chemotherapeutic drug develo...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
World Association for Sustainable Development
2019
|
| Subjects: | |
| Online Access: | https://repository.londonmet.ac.uk/6408/1/IJFNPH_V11_N1-2_2019_%20SHRSTHA%20ET%20AL.pdf |
| _version_ | 1804072599437705216 |
|---|---|
| author | Shrestha, Sony C. White, Kenneth Minelli, Caterina Tewfik, Ihab Thapa, Panna Tewfik, Sundus |
| author_facet | Shrestha, Sony C. White, Kenneth Minelli, Caterina Tewfik, Ihab Thapa, Panna Tewfik, Sundus |
| author_sort | Shrestha, Sony C. |
| collection | LMU |
| description | Background:
Nanomedicine refers to the application of nanotechnology to improve the diagnosis, monitoring and treatment of diseases. Although the primary application was originally in oncology, nanomedicine has witnessed substantial scientific interest and growth beyond chemotherapeutic drug development.
Approach:
Despite the widespread prevalence of cardiovascular diseases (CVDs), limitations remain in their clinical management regardless of the major technological advancement in diagnostic and therapeutic modalities available. In the present context, flourishing research in cardiovascular nanomedicine is expected to address the current challenges and bring about much sought for solutions to the identification and management of the progression of CVDs.
Practical Implications:
As the research portfolio of nanomedicine expands, it can have a significant impact on the management of CVDs, particularly atherosclerosis. Nanotechnology presents an opportunity to address the components of atherosclerotic plaque and enhance the therapeutic approaches to atherogenesis. |
| first_indexed | 2024-07-09T04:01:42Z |
| format | Article |
| id | oai:repository.londonmet.ac.uk:6408 |
| institution | London Metropolitan University |
| language | English |
| last_indexed | 2024-07-09T04:01:42Z |
| publishDate | 2019 |
| publisher | World Association for Sustainable Development |
| record_format | eprints |
| spelling | oai:repository.londonmet.ac.uk:64082021-03-16T09:51:12Z http://repository.londonmet.ac.uk/6408/ A perspective on nanomedicine: focus on cardiovascular medicine Shrestha, Sony C. White, Kenneth Minelli, Caterina Tewfik, Ihab Thapa, Panna Tewfik, Sundus 570 Life sciences; biology 610 Medicine & health Background: Nanomedicine refers to the application of nanotechnology to improve the diagnosis, monitoring and treatment of diseases. Although the primary application was originally in oncology, nanomedicine has witnessed substantial scientific interest and growth beyond chemotherapeutic drug development. Approach: Despite the widespread prevalence of cardiovascular diseases (CVDs), limitations remain in their clinical management regardless of the major technological advancement in diagnostic and therapeutic modalities available. In the present context, flourishing research in cardiovascular nanomedicine is expected to address the current challenges and bring about much sought for solutions to the identification and management of the progression of CVDs. Practical Implications: As the research portfolio of nanomedicine expands, it can have a significant impact on the management of CVDs, particularly atherosclerosis. Nanotechnology presents an opportunity to address the components of atherosclerotic plaque and enhance the therapeutic approaches to atherogenesis. World Association for Sustainable Development 2019 Article PeerReviewed text en https://repository.londonmet.ac.uk/6408/1/IJFNPH_V11_N1-2_2019_%20SHRSTHA%20ET%20AL.pdf Shrestha, Sony C., White, Kenneth, Minelli, Caterina, Tewfik, Ihab, Thapa, Panna and Tewfik, Sundus (2019) A perspective on nanomedicine: focus on cardiovascular medicine. International Journal of Food, Nutrition and Public Health, 11 (1/2). pp. 97-119. ISSN 2042-5988 https://www.wasd.org.uk/publications/journals/ijfnph/ijfnph-articles/?wpdmc=ijfnph-v11-n1-2-2019 |
| spellingShingle | 570 Life sciences; biology 610 Medicine & health Shrestha, Sony C. White, Kenneth Minelli, Caterina Tewfik, Ihab Thapa, Panna Tewfik, Sundus A perspective on nanomedicine: focus on cardiovascular medicine |
| title | A perspective on nanomedicine: focus on cardiovascular medicine |
| title_full | A perspective on nanomedicine: focus on cardiovascular medicine |
| title_fullStr | A perspective on nanomedicine: focus on cardiovascular medicine |
| title_full_unstemmed | A perspective on nanomedicine: focus on cardiovascular medicine |
| title_short | A perspective on nanomedicine: focus on cardiovascular medicine |
| title_sort | perspective on nanomedicine focus on cardiovascular medicine |
| topic | 570 Life sciences; biology 610 Medicine & health |
| url | https://repository.londonmet.ac.uk/6408/1/IJFNPH_V11_N1-2_2019_%20SHRSTHA%20ET%20AL.pdf |
| work_keys_str_mv | AT shresthasonyc aperspectiveonnanomedicinefocusoncardiovascularmedicine AT whitekenneth aperspectiveonnanomedicinefocusoncardiovascularmedicine AT minellicaterina aperspectiveonnanomedicinefocusoncardiovascularmedicine AT tewfikihab aperspectiveonnanomedicinefocusoncardiovascularmedicine AT thapapanna aperspectiveonnanomedicinefocusoncardiovascularmedicine AT tewfiksundus aperspectiveonnanomedicinefocusoncardiovascularmedicine AT shresthasonyc perspectiveonnanomedicinefocusoncardiovascularmedicine AT whitekenneth perspectiveonnanomedicinefocusoncardiovascularmedicine AT minellicaterina perspectiveonnanomedicinefocusoncardiovascularmedicine AT tewfikihab perspectiveonnanomedicinefocusoncardiovascularmedicine AT thapapanna perspectiveonnanomedicinefocusoncardiovascularmedicine AT tewfiksundus perspectiveonnanomedicinefocusoncardiovascularmedicine |